Clinical Trial Update: Apatinib for Advanced Lung Squmamous Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for apatinib in advanced lung squamous cell carcinoma being conducted by Xuzhou Central Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Xuzhou Central Hospital | Conditions: Lung Squamous Cell Carcinoma | Phase 4 | Status: UNKNOWN